Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
875 DKK | +0.95% | +1.07% | +25.41% |
Apr. 25 | NOVO NORDISK : JP Morgan gives a Buy rating | ZD |
Apr. 25 | Scholz promises support for pharma sector in Germany as Merck invests | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.41% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+12.66% | 233B | |
+5.22% | 201B | |
-9.98% | 193B | |
-12.26% | 143B | |
-6.47% | 144B | |
+0.72% | 123B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Novo Nordisk Reports Higher Semaglutide Doses Reach Targets in Late-Stage Trial